| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |